Mark Vachon's most recent trade in Bluebird bio Inc was a trade of 49,850 Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 49,850 | 49,850 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Nov 2024 | 24,900 | 49,941 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 21,600 | 21,600 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 10,790 | 25,041 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 4,353 | 14,251 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 10,038 | 10,038 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,384 | 7,384 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 6,241 | 9,898 (0%) | 0% | 0 | Common Stock | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 3,938 | 3,938 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 2,953 | 2,953 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Bluebird bio Inc | Mark Vachon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 3,109 | 6,766 (0%) | 0% | 0 | Common Stock |